Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BAROS | Mallinckrodt | N-018509 DISCN | 1985-08-07 | 1 products |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Overweight | D050177 | — | E66.3 | — | — | — | 1 | 2 | 3 |
Weight loss | D015431 | — | — | — | — | — | 1 | 1 | 2 |
Delayed graft function | D051799 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | 1 | — | — | 1 |
Aphthous stomatitis | D013281 | EFO_0003938 | K12.0 | — | — | 1 | — | — | 1 |
Ulcer | D014456 | MPATH_579 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pinealoma | D010871 | — | — | — | 1 | — | — | — | 1 |
Neuroblastoma | D009447 | EFO_0000621 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 8 | — | — | — | 1 | 9 |
Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
Failure to thrive | D005183 | — | — | — | — | — | — | 1 | 1 |
Dwarfism | D004392 | — | E34.31 | — | — | — | — | 1 | 1 |
Dyslipidemias | D050171 | — | — | — | — | — | — | 1 | 1 |
Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | — | — | — | 1 | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 1 | 1 |
Syndrome | D013577 | — | — | — | — | — | — | 1 | 1 |
Ambulatory care | D000553 | — | — | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Sars-cov-2 | D000086402 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Tartaric acid |
INN | _ |
Description | 2,3-dihydroxybutanedioic acid is a tetraric acid that is butanedioic acid substituted by hydroxy groups at positions 2 and 3. It has a role as a human xenobiotic metabolite and a plant metabolite. It is a conjugate acid of a 3-carboxy-2,3-dihydroxypropanoate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(O)[C@@H](O)[C@H](O)C(=O)O |
PDB | — |
CAS-ID | 147-71-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1200861 |
ChEBI ID | 15672 |
PubChem CID | 875 |
DrugBank | DB01694 |
UNII ID | W4888I119H (ChemIDplus, GSRS) |